Streetbeat News

Revenues

USLM

United States Lime Inc. (NASDAQ:USLM) has seen a significant stock price increase, with a 19.59% rise over the past month and 176.62% over the past year. The company's P/E ratio of 35.33 is higher than the industry average of 24.1, suggesting potential overvaluation but also indicating investor optimism for future performance.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 3:30 pm

AAPL

GSAT

Globalstar's stock surged after announcing an expanded $1.1 billion services agreement with Apple, enhancing satellite services and infrastructure. Apple will fund the network's construction and gain a 20% equity stake in Globalstar Licensee.

Portfolio Pulse from Anusuya Lahiri

November 01, 2024 | 3:10 pm

NOW

The article provides a comprehensive analysis of ServiceNow (NYSE:NOW) in comparison to its competitors in the software industry. It highlights ServiceNow's high P/E and P/S ratios, suggesting potential overvaluation, while its low P/B ratio indicates possible undervaluation based on book value. Despite strong revenue growth, ServiceNow lags behind peers in ROE, EBITDA, and gross profit, reflecting lower profitability. The company has a favorable debt-to-equity ratio, indicating a strong financial position.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 3:00 pm

AMD

The article provides a comparative analysis of Advanced Micro Devices (AMD) against its competitors in the Semiconductors & Semiconductor Equipment industry. It highlights AMD's high P/E ratio, low P/B and P/S ratios, and strong revenue growth, but notes its lower ROE, EBITDA, and gross profit compared to industry averages. AMD's low debt-to-equity ratio is seen as a positive indicator of financial health.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 3:00 pm

The article evaluates Visa's performance against its competitors in the Financial Services industry, highlighting its financial metrics, market position, and growth prospects. Visa shows potential for growth with a low P/E ratio, high profitability, and operational efficiency, but its revenue growth lags behind the industry average.

Portfolio Pulse from Benzinga Insights

November 01, 2024 | 3:00 pm

ASML

TSM

Taiwan Semiconductor Manufacturing Co (TSM) is set to acquire high-precision equipment from ASML Holding NV (ASML) by year-end, enhancing its chipmaking capabilities. ASML will supply high NA EUV lithography machines, each valued at $350 million. Analyst Ming-Chi Kuo predicts a potential pricing standoff between the two companies. ASML faces geopolitical tensions as the U.S. pressures it to limit technology sales to China. ASML's 2025 sales forecast has been adjusted due to weaker demand.

Portfolio Pulse from Anusuya Lahiri

November 01, 2024 | 2:58 pm

PEV

Phoenix Motor Inc. (NASDAQ:PEV) reported a significant increase in Q2 revenues, rising from $1.16 million to $12.03 million. Despite this, shares fell 3.6% to $0.44. The company delivered five electric buses to UC Irvine and secured a contract for four more to UC San Diego. Gross profit improved, and EPS increased from a loss of $(0.15) to $(0.06).

Portfolio Pulse from Lekha Gupta

November 01, 2024 | 2:51 pm

XPEV

XPeng shares rose following the announcement of a year-over-year increase in October delivery results.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2024 | 2:50 pm

DKNG

FOX

FOXA

MGM

The Los Angeles Dodgers' 2024 World Series win and the Kansas City Chiefs' Super Bowl victories are seen as potential predictors for the 2024 presidential election. The Dodgers' win could boost Fox Corp's financial results due to high viewership. Betting odds favor Trump over Harris for the election. The Dodgers and Chiefs are favorites for future championships.

Portfolio Pulse from Chris Katje

November 01, 2024 | 2:45 pm

CDXC

ELAB

EPIX

LXRX

PRLB

TILE

U.S. stocks rose with the Dow Jones gaining over 400 points. The U.S. economy added 12,000 jobs in October, below expectations. ChromaDex, Proto Labs, and Interface saw significant stock price increases due to strong earnings reports, while ESSA Pharma, Elevai Labs, and Lexicon Pharmaceuticals experienced declines.

Portfolio Pulse from Avi Kapoor

November 01, 2024 | 2:43 pm